1. Aiken, C. B., & Orr, C. (2010). Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature. Psychiatry (Edgmont), 7, 27–32.
2. American Psychiatric Association. (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). The American Journal of Psychiatry, 159(4 Suppl), 1–50.
3. Anderson, G. D., Gidal, B. E., Messenheimer, J. A., & Gilliam, F. G. (2002). Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin. Epilepsy Research, 49, 211–217.
4. Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010). Suicide-related events in patients treated with antiepileptic drugs. The New England Journal of Medicine, 363, 542–551.
5. Argikar, U. A., & Remmel, R. P. (2009). Variation in glucuronidation of lamotrigine in human liver microsomes. Xenobiotica, 39, 355–363.